IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 20-F SEC Filings
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
NYMOX PHARMACEUTICAL CORP, 20-F, 2000-05-15
NYMOX PHARMACEUTICAL CORP, 20-F, 1999-05-14
TRINITY BIOTECH PLC, 20-F, 1998-10-09
NYMOX PHARMACEUTICAL CORP, 20-F, 1998-05-08
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
